BR112013018679A2 - agente para o tratamento da alopecia - Google Patents

agente para o tratamento da alopecia

Info

Publication number
BR112013018679A2
BR112013018679A2 BR112013018679A BR112013018679A BR112013018679A2 BR 112013018679 A2 BR112013018679 A2 BR 112013018679A2 BR 112013018679 A BR112013018679 A BR 112013018679A BR 112013018679 A BR112013018679 A BR 112013018679A BR 112013018679 A2 BR112013018679 A2 BR 112013018679A2
Authority
BR
Brazil
Prior art keywords
agent
treating alopecia
alopecia
treating
Prior art date
Application number
BR112013018679A
Other languages
English (en)
Other versions
BR112013018679B1 (pt
Inventor
Kyoki Endo
Original Assignee
Igisu Co Ltd
Kyoko Endo
Yori Endo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igisu Co Ltd, Kyoko Endo, Yori Endo filed Critical Igisu Co Ltd
Publication of BR112013018679A2 publication Critical patent/BR112013018679A2/pt
Publication of BR112013018679B1 publication Critical patent/BR112013018679B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112013018679-8A 2011-01-21 2012-01-20 Agente para o tratamento da alopecia e uso de um peptídeo natriurético do tipo c BR112013018679B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011-011437 2011-01-21
JP2011011437 2011-01-21
PCT/JP2012/051272 WO2012099258A1 (ja) 2011-01-21 2012-01-20 脱毛症治療剤

Publications (2)

Publication Number Publication Date
BR112013018679A2 true BR112013018679A2 (pt) 2016-10-18
BR112013018679B1 BR112013018679B1 (pt) 2022-04-12

Family

ID=46515875

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013018679-8A BR112013018679B1 (pt) 2011-01-21 2012-01-20 Agente para o tratamento da alopecia e uso de um peptídeo natriurético do tipo c

Country Status (14)

Country Link
US (4) US20120238498A1 (pt)
EP (2) EP2666475B1 (pt)
JP (1) JP5261620B2 (pt)
KR (1) KR101954869B1 (pt)
CN (2) CN103547282A (pt)
AU (2) AU2012207816B2 (pt)
BR (1) BR112013018679B1 (pt)
CA (1) CA2825382C (pt)
DK (1) DK2666475T3 (pt)
ES (1) ES2647680T3 (pt)
HU (1) HUE035584T2 (pt)
MX (1) MX353295B (pt)
TW (2) TW201811360A (pt)
WO (1) WO2012099258A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101226165B1 (ko) 2009-07-23 2013-01-24 가부시키가이샤 이기스 피부 외용제 조성물
MX353295B (es) 2011-01-21 2018-01-08 Endo Kyoko Agente para el tratamiento de la alopecia.
WO2016175559A2 (ko) * 2015-04-28 2016-11-03 (주) 메드빌 지모와 두릅의 복합 추출물을 함유하는 탈모 방지 및 발모 개선용 조성물
WO2016194855A1 (ja) * 2015-05-29 2016-12-08 株式会社イギス 環状ペプチド並びに該環状ペプチドを含む医薬、外用剤および化粧料
EP3330280A4 (en) * 2015-07-31 2019-06-12 Igisu Co., Ltd. CYCLIC PEPTIDE CNP AND MEDICINE, PREPARATION FOR EXTERNAL USE AND COSMETIC PRODUCT, CONTAINING ALL OF SAID CYCLIC PEPTIDE
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
CN105617360B (zh) * 2015-12-04 2018-12-21 中国农业大学 C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用
BR112018068886A2 (pt) * 2016-03-18 2019-01-22 Caregen Co Ltd conjugado de finasterida com peptídeo
CA3018561A1 (en) * 2016-03-21 2017-09-28 Rhode Island Council On Postsecondary Education Ph-sensitive peptides
US11312758B2 (en) 2016-08-18 2022-04-26 National University Of Singapore Peptides with vasodilatory and/or diuretic functions
KR101948238B1 (ko) * 2016-08-19 2019-02-14 (주)케어젠 미녹시딜과 펩타이드의 결합체
WO2018045244A1 (en) * 2016-09-01 2018-03-08 Jds Therapeutics, Llc Magnesium biotinate compositions and methods of use
US9956158B2 (en) * 2016-09-08 2018-05-01 Synergistic Therapeutics, Llc Topical hair growth formulation
CN108424446A (zh) * 2017-02-13 2018-08-21 成都贝爱特生物科技有限公司 新的重组人心房利钠肽突变体的制备及其应用
EP3760214A4 (en) * 2018-02-28 2021-11-17 Mother"S Pharmaceutical Co.,Ltd. COMPOSITION TO PREVENT HAIR LOSS OR STIMULATE HAIR GROWTH
CN109011138A (zh) * 2018-05-07 2018-12-18 北京全贵医疗科技有限公司 基于头部图像的头部理疗方法及装置
WO2020123312A1 (en) 2018-12-09 2020-06-18 Weinberg Assa Method to prevent and treat macular degeneration by vasodilators
WO2020154304A1 (en) * 2019-01-24 2020-07-30 Weinberg Assa Method to prevent and treat alopecia by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers
TW202419463A (zh) 2022-11-02 2024-05-16 丹麥商諾佛 儂迪克股份有限公司 Cnp化合物
KR102677730B1 (ko) * 2023-03-27 2024-06-27 나인바이오팜 주식회사 지방 분해 효능을 갖는 펩타이드 및 이의 용도

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804650A (en) 1986-10-28 1989-02-14 Biotechnology Research Associates, J.V. Analogs of atrial natriuretic peptides
US5047397A (en) 1988-08-26 1991-09-10 California Biotechnology Inc. Linear analogs of atrial natriuretic peptides
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5204328A (en) 1990-06-26 1993-04-20 Merck & Co., Inc. Peptides having atrial natriuretic factor activity
JP2809533B2 (ja) * 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
JPH05207891A (ja) 1991-03-08 1993-08-20 Shionogi & Co Ltd 脳性ナトリウム利尿ペプチドの製造方法
WO1994020534A1 (en) 1993-03-03 1994-09-15 Mayo Foundation For Medical Education And Research Vasonatrin peptide and analogs thereof
TW382595B (en) * 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
US5965533A (en) 1997-05-23 1999-10-12 Baxter International Inc. Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
JP3799465B2 (ja) 1998-09-28 2006-07-19 参天製薬株式会社 ナトリウム利尿ペプチドを有効成分とする涙液分泌促進または角結膜障害治療用点眼剤
US6407211B1 (en) 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
IL142118A0 (en) * 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
US7655772B2 (en) 2002-09-06 2010-02-02 University Of South Florida Materials and methods for treatment of allergic diseases
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US7887842B2 (en) * 2003-02-07 2011-02-15 Teikoku Pharma Usa, Inc. Methods of administering a dermatological agent to a subject
US20070270337A1 (en) 2003-06-13 2007-11-22 Daiichi Asubio Pharma Co., Ltd. Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
KR100509446B1 (ko) 2003-06-19 2005-08-22 세메스 주식회사 반도체 제조 공정에서 사용되는 약액 공급 장치
CN101208353B (zh) 2003-06-20 2011-12-14 梅约医学教育与研究基金会 脑利尿钠肽的同种型
GB2403533A (en) * 2003-06-30 2005-01-05 Orion Corp Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
EP1730181A2 (en) 2004-01-27 2006-12-13 Compugen USA, Inc. Novel brain natriuretic peptide variants and methods of use thereof
JP2007525213A (ja) 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ，インク． 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
CA2561530C (en) 2004-03-31 2014-04-22 Kazuwa Nakao Therapeutic or prophylactic agent for arthritis
CN1960757A (zh) 2004-03-31 2007-05-09 中尾一和 身高增加用组合物
CA2576852A1 (en) 2004-08-11 2006-02-23 Alza Corporation Apparatus and method for transdermal delivery of natriuretic peptides
EP1810716A1 (de) 2005-12-23 2007-07-25 Deutsches Zentrum für Luft- und Raumfahrt e.V. Verfahren zur Bräunung der Haut
US7196223B2 (en) 2005-05-03 2007-03-27 Solutia, Inc. Higher alcohols for solvents in amine production
JP3830960B1 (ja) * 2005-08-12 2006-10-11 建仁 河乃 育毛物質
BRPI0716416A2 (pt) 2006-08-08 2016-10-11 Mayo Foundation polipeptídeo substancialmente puro entre 37 e 47 besíduos de aminoácido de comprimento, ácido nucléico isolado, vetor: célula hospedeira e composição farmacêutica
JPWO2008032450A1 (ja) 2006-09-15 2010-01-21 国立大学法人京都大学 脂肪肝の予防剤および／または治療剤
KR100842392B1 (ko) 2006-10-10 2008-07-01 주식회사 일진글로벌 토크를 측정할 수 있는 구동휠시스템
JP2008140125A (ja) 2006-12-01 2008-06-19 Rakuten Inc サービス予約システム、予約登録装置、参加者募集方法及び参加者募集処理プログラム
US20120034183A1 (en) 2006-12-19 2012-02-09 Michael Cohen Compositions and methods for growing embryonic stem cells
JP5010913B2 (ja) * 2006-12-31 2012-08-29 寿子 小出 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法
JP2010168283A (ja) 2007-04-24 2010-08-05 Yamaguchi Univ ナトリウム利尿ペプチドを有効成分とする肝硬変・前癌病変の抑制剤
JP5207316B2 (ja) 2007-05-10 2013-06-12 国立大学法人名古屋大学 腹膜線維化抑制用医薬組成物
JP2009013122A (ja) * 2007-07-06 2009-01-22 Masaru Okura 育毛剤
WO2009046865A2 (en) 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Cholecystokinin-33 alone or in combination with trap-14 as therapeutic agent
EP2187953A2 (en) 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of a peptide as a therapeutic agent
AU2008326327A1 (en) 2007-11-21 2009-05-28 Biomarin Pharmaceutical Inc. Variants of C-type natriuretic peptide
US8455438B2 (en) * 2008-12-29 2013-06-04 Mayo Foundation For Medical Education And Research Natriuretic polypeptides for reducing or preventing restenosis
US20110014180A1 (en) * 2009-07-16 2011-01-20 Masafumi Koide Preparations for tissue restoration containing atrial diuretic hormone and family molecules as active ingredients; method of restoring tissue using the preparation; agents for growing, restoring, promoting growth of hair and agents for promoting restoration of skin tissue and cardiac muscle tissue containing atrial diuretic hormone family molecules as active ingredients; method of growing, restoring, promoting growth of hair by using the agents; and method of promoting restoration of skin tissue and cardiac muscle tissue
KR101226165B1 (ko) * 2009-07-23 2013-01-24 가부시키가이샤 이기스 피부 외용제 조성물
KR101229546B1 (ko) * 2009-08-27 2013-02-05 쿄고 엔도 비염 치료제
MX353295B (es) 2011-01-21 2018-01-08 Endo Kyoko Agente para el tratamiento de la alopecia.

Also Published As

Publication number Publication date
CA2825382C (en) 2020-07-28
KR101954869B1 (ko) 2019-05-30
EP2666475A8 (en) 2014-03-19
US20170065680A1 (en) 2017-03-09
CN103547282A (zh) 2014-01-29
AU2012207816B2 (en) 2017-03-09
AU2012207816A1 (en) 2013-08-22
KR20140041437A (ko) 2014-04-04
US20140315810A1 (en) 2014-10-23
JPWO2012099258A1 (ja) 2014-06-30
EP2666475B1 (en) 2017-08-16
EP2666475A4 (en) 2014-12-31
ES2647680T3 (es) 2017-12-26
HUE035584T2 (en) 2018-05-28
TWI619505B (zh) 2018-04-01
US9480728B2 (en) 2016-11-01
TW201244734A (en) 2012-11-16
US20120238498A1 (en) 2012-09-20
DK2666475T3 (da) 2017-11-20
US11571464B2 (en) 2023-02-07
EP3269382A1 (en) 2018-01-17
AU2017203793A1 (en) 2017-06-22
BR112013018679B1 (pt) 2022-04-12
CN110801514A (zh) 2020-02-18
JP5261620B2 (ja) 2013-08-14
MX2013008422A (es) 2013-10-03
US9808511B2 (en) 2017-11-07
CA2825382A1 (en) 2012-07-26
MX353295B (es) 2018-01-08
WO2012099258A1 (ja) 2012-07-26
TW201811360A (zh) 2018-04-01
EP2666475A1 (en) 2013-11-27
US20180133289A1 (en) 2018-05-17

Similar Documents

Publication Publication Date Title
BR112013018679A2 (pt) agente para o tratamento da alopecia
BR112014032105A2 (pt) método para o tratamento de câncer
BR112014009528A2 (pt) métodos e composições para tratar eritropoiese ineficaz
BR112013019732A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
CR20140119A (es) Composición y apósito para tratamiento de heridas
BR112014013246A8 (pt) composição catalisadora, e, método para tratar nox
BR112013007678A2 (pt) método para tratamento de doenças alérgicas
DK2707030T3 (da) Cancerbehandlinger
CO6890100A2 (es) Tratamientos de combinación para hepatitis c
BR112013016491A2 (pt) método para tratamento de têxtil
BR112015028115A2 (pt) métodos e composições para o tratamento de câncer
BR112014032053A2 (pt) composto, composição farmacêutica, utilização de um composto, método para o tratamento de câncer e invenção
BR112014031896A2 (pt) composto, composição farmacêutica, e, método para o tratamento de um distúrbio
BR112015011262A2 (pt) artigo absorvente e método para produzir um artigo absorvente
BR112014022694A2 (pt) novos métodos e composições para o tratamento de doença
BR112014031512A2 (pt) composição cosmética e método para o tratamento cosmético.
BR112015006512A2 (pt) composição para tratar tecidos biológicos danificados
BR112014004414A2 (pt) composições e métodos para tratar doença neurodegenerativa
BR112013023142A2 (pt) método de tratamento de cabelos
BR112014031899A8 (pt) composto, composição farmacêutica, e, método para tratamento de um distúrbio
EP2786738A4 (en) HAIR TREATMENT COMPOSITION
BR112014029487A2 (pt) método para o tratamento cosmético
BR112013022306A2 (pt) método, e, composição
BR112014002102A2 (pt) curativo para ferimentos e métodos para fazer o curativo para ferimentos
BR112013028890A2 (pt) composições e métodos para o tratamento de câncer

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/01/2012, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.